Mather Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.8K Sell
1,427
-4
-0.3% -$174 ﹤0.01% 1114
2026
Q2
$61K Buy
1,431
+204
+17% +$9.12K ﹤0.01% 1058
2026
Q1
$59.1K Buy
+1,227
New +$57.2K ﹤0.01% 1023
2025
Q4
– Sell
-1,242
Closed -$58.6K – 1504
2025
Q3
$58.6K Buy
+1,242
New +$59.9K ﹤0.01% 875
2025
Q2
– Sell
-1,261
Closed -$69.9K – 1560
2025
Q1
$69.9K Sell
1,261
-49
-4% -$2.65K ﹤0.01% 842
2024
Q4
$63.2K Buy
1,310
+72
+6% +$3.66K ﹤0.01% 826
2024
Q3
$71.3K Sell
1,238
-710
-36% -$38.3K ﹤0.01% 811
2024
Q2
$94.7K Buy
1,948
+1,595
+452% +$76.9K ﹤0.01% 823
2024
Q1
$17.6K Buy
+353
New +$17.2K ﹤0.01% 1081
2022
Q2
– Sell
-10,977
Closed -$564K – 468
2022
Q1
$564K Sell
10,977
-544
-5% -$28.1K 0.01% 245
2021
Q4
$577K Buy
+11,521
New +$570K 0.01% 205

Other funds holding SNY

Mather Group's SNY Position: Q3 2026 in Review

Mather Group reduced its Sanofi (SNY) stake by 0.28% in Q3 2026, selling an estimated $174 and leaving 1,427 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Mather Group first reported a position in SNY in Q4 2021 and has held it in 11 quarters since. The position peaked at $577K in Q4 2021. 140 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Mather Group held 1,427 shares of Sanofi worth $58.8K as of Q3 2026.
  • Mather Group sold 4 Sanofi shares in Q3 2026, an estimated $174.
  • Sanofi made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1114 holding.
  • Mather Group first reported a position in Sanofi in Q4 2021 and has held it in 11 quarters since.
  • Mather Group's Sanofi position peaked at $577K in Q4 2021.
  • 140 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.